paclitaxel,CTX-009
Compass Therapeutics
[]
compass therapeutics announces that the phase 2 data of ctx-009 in combination with paclitaxel in patients with biliary tract cancers (btc) will be presented at the asco gi cancers symposium on january 20, 2023 - to host investor event on monday, januar... 
CEO Of Digital Media Online